Virtual Reality on the IMC

计划入组 40 人 · 首次发布于 2022 年 5 月 19 日

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

计划入组 75 人 · 首次发布于 2019 年 6 月 4 日

A Study of IMC-CS4 in Subjects With Advanced Solid Tumors

计划入组 72 人 · 首次发布于 2011 年 5 月 3 日

IMC-003

IMC-M113V

IMC-4022

Virios Therapeutics

United States

IMV Inc.

KMC (KUEI MENG) INTERNATIONAL INC.

Taiwan

Immunocore Outlines 2026 Strategic Priorities with Focus on Melanoma Franchise Expansion and Pipeline Advancement

ImmuneOncia's CD47 Antibody IMC-002 Shows 30% Response Rate in Advanced Hepatocellular Carcinoma Trial

Immunocore's IMC-I109V Shows Promising Antiviral Activity in Phase 1 Hepatitis B Trial